Old Disease, New Faces; Mucormycosis in Post SARS Covid-19 Era: A Review

Abstract Mucormycosis is a severe yet uncommon angioinvasive fungal infection that progresses rapidly, making early diagnosis and treatment essential to reduce its high mortality and morbidity rates. The disease arises primarily from inhalation of filamentous (hyphal) fungal spores, particularly in immunocompromised individuals. This review highlights the etiopathogenesis of mucormycosis, the fatal consequences of rhino cerebral mucormycosis, its complex association with COVID-19, and the latest advances in diagnostic and therapeutic approaches.